ebook img

European Journal of Pharmacology 1994: Vol 261 Index PDF

13 Pages·1994·2.7 MB·English
by  
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview European Journal of Pharmacology 1994: Vol 261 Index

European Journal of Pharmacology 261 (1994) 339-341 Author index Adner, M., Erlinge, D., Salford, L.G., Yee, F., Wahlestedt, C. and Dazzi, L., see Imperato, A. (261) 205 Edvinsson, L. De Castro, M., Mota-Filipe, H., Caneira, M., Giado-T. Rico, J.M., Human endothelin ET, receptor antisense oligodeoxynucleotides Scott-Burden, T. and Vanhoutte, P.M. inhibit endothelin-1 evoked vasoconstriction (261) 281 pt-Propranolol augments production of NO’ induced by cy- Albinsson, A., Bjork, A., Svartengren, J., Klint, T. and Andersson, G. tokines in cultured aortic smooth muscle of the rat (261) 199 Preclinical pharmacology of FG5893: a potential anxiolytic drug Decker, M.W., Curzon, P., Brioni, J.D. and Arnerié, S.P. with high affinity for both 5-HT,, and 5-HT,, receptors (261) Effects of ABT-418, a novel cholinergic channel ligand, on place 285 learning in septal-lesioned rats (261) 217 Aldasoro, M., see Martinez, C. (261) 73 De Giuli, P., see Emanuelli, G. (261) 265 Amenta, F., see Kobayashi, Y. (261) 229 De Kimpe, S.J., Tielemans, W., Van Heuven-Nolsen, D. and Ni- Andersson, G., see Albinsson, A. (261) 285 jkamp, F.P. Argiolas, A., see Stancampiano, R. (261) 149 Reversal of bradykinin-induced relaxation to contraction after Argiolas, L., see Marano, G. (261) 121 interferon-y in bovine isolated mesenteric arteries (261) 111 Arnerié¢, $.P., see Decker, M.W. (261) 217 De Martino, A., see Emanuelli, G. (261) 265 Dent, E.L., see Cheng, D.Y. (261) 223 Barbaccia, M.L., Roscetti, G., Trabucchi, M., Cuccheddu, T., Con- Descarries, L., see El Mansari, M. (261) 171 cas, A. and Biggio, G. DeWitt, B.J., see Cheng, D.Y. (261) 223 Neurosteroids in the brain of handling-habituated and naive rats: Di Giannuario, A., see Capasso, A. (261) 209 effect of CO, inhalation (261) 317 Doods, H.N., see Coppes, R.P. (261) 311 Battaglia, E., see Emanuelli, G. (261) 265 Dughera, L., see Emanuelli, G. (261) 265 Benavides, J., see Rouquier, L. (261) 59 Dzwonczyk, S., see Sargent, C.A. (261) 25 Beninger, R.J., see Mallet, P.E. (261) RS Bennett, M.R., see Karunanithi, S. (261) 17 Edvinsson, L., see Adner, M. (261) 281 Bertrand, C., see Ricciardolo, F.L.M. (261) 127 El Mansari, M., Radja, F., Ferron, A., Reader, T.A., Molina- Biggio, G., see Barbaccia, M.L. (261) 317 Holgado, E. and Descarries, L. Biggio, G., see Imperato, A. (261) 205 Hypersensitivity to serotonin and its agonists in serotonin- Bjork, A., see Albinsson, A. (261) 285 hyperinnervated neostriatum after neonatal dopamine denerva- Brioni, J.D., see Decker, M.W. (261) 217 tion (261) 171 Camussi, G., see Emanuelli, G. (261) 265 Emanuelli, G., Montrucchio, G., Dughera, L., Gaia, E., Lupia, E., Caneira, M., see De Castro, M. (261) 199 Battaglia, E., De Martino, A., De Giuli, P., Gubetta, L. and Capasso, A., Sorrentino, L., Di Giannuario, A., Pieretti, S. and Camussi, G. Loizzo, A. Role of platelet activating factor in acute pancreatitis induced by Effect of des-tyrosine-y-endorphin on neocortical spike-and-wave lipopolysaccharides in rabbits (261) 265 spindling in DBA/2J mice (261) 209 Erlinge, D., see Adner, M. (261) 281 Cavallotti, D., see Kobayashi, Y. (261) 229 Chan, B., see Ricciardolo, F.L.M. (261) 127 Feniuk, W. and Humphrey, P.P.A. Cheng, D.Y., DeWitt, B.J., Dent, E.L., Nossaman, B.D. and Ka- Somatostatin-induced inhibition of neurotransmission in the dowitz, PJ. mouse isolated vas deferens is resistant to pertussis toxin (261) Analysis of responses to angiotensin IV in the pulmonary vascu- 333 lar bed of the cat (261) 223 Ferron, A., see El Mansari, M. (261) 171 Chisholm, J.C., see Hunnicutt, Jr., E.J. (261) R1 Frew, R., see Lundy, P.M. (261) 79 Chuan, P., see Martinez, C. (261) 73 Fuentes, J.A., see Hernando, F. (261) 257 Claustre, Y., see Rouquier, L. (261) 59 Fujibayashi, K., Sakamoto, K., Watanabe, M. and lizuka, Y. Cole, J.C., see Rodgers, R.J. (261) 321 Pharmacological properties of R-84760, a novel x-opioid receptor Concas, A., see Barbaccia, M.L. (261) 317 agonist (261) 133 Coppes, R.P., Smit, J., Geurtsen, A.M.S., Roffel, A.F., Dahléf, C., Fujinami, T., see Saeki, T. (261) 249 Doods, H.N. and Zaagsma, J. Fujita, A., see Maehara, T. (261) 163 Heterogeneity of prejunctional neuropeptide Y receptors inhibit- ing noradrenaline overflow in the portal vein of freely moving Gaia, E., see Emanuelli, G. (261) 265 rats (261) 311 Gainetdinov, R.R., Grekhova, T.V., Sotnikova, T.D. and Rayevsky, Cuccheddu, T., see Barbaccia, M.L. (261) 317 KS. Curzon, P., see Decker, M.W. (261) 217 Dopamine D, and D, receptor preferring antagonists differen- tially affect striatal dopamine release and metabolism in con- Dahléf, C., see Coppes, R.P. (261) 311 scious rats (261) 327 Davis, J.N., see Hunnicutt, Jr., EJ. (261) R1 Geppetti, P., see Ricciardolo, F.L.M. (261) 127 340 Author index / European Journal of Pharmacology 261 (1994) 339-341 Gessa, G.L., see Imperato, A. (261) 205 Laurent, S., see Yin, Y. (261) 97 Geurtsen, A.M.S., see Coppes, R.P. (261) 311 Lavidis, N.A., see Karunanithi, S. (261) 17 Giao-T. Rico, J.M., see De Castro, M. (261) 199 Lieu, A.T. and Reid, J.J. Grekhova, T.V., see Gainetdinov, R.R. (261) 327 Changes in the responsiveness to endothelin-1 in isolated atria Grover, G.J., see Sargent, C.A. (261) 25 from diabetic rats (261) 33 Gubetta, L., see Emanuelli, G. (261) 265 Lluch, S., see Martinez, C. (261) 73 Guiot, Y., Henquin, J.-C. and Rahier, J. Loizzo, A., see Capasso, A. (261) 209 Effects of glibenclamide on pancreatic B-cell proliferation in vivo Long, J.B. and Skolnick, P. (261) 157 1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury (261) 295 Lundberg, J.M., see Modin, A. (261) 185 Haberny, K.A. and Young, G.A. Interactive effects of MK-801 and morphine on EEG, EEG Lundy, P.M. and Frew, R. power spectra and behavior in rats: 1. Morphine tolerance devel- Effect of w-agatoxin-I[VA on autonomic neurotransmission (261) 79 opment (261) 1 Haberny, K.A. and Young, G.A. Lupia, E., see Emanuelli, G. (261) 265 Interactive effects of MK-801 and morphine on EEG, EEG power spectra and behavior in rats: I]. Morphine dependence Maehara, T., Fujita, A., Suthamnatpong, N., Takeuchi, T. and Hata, F. (261) 11 Hansen, P.R. Differences in relaxant effects of cyclic GMP on skinned muscle In vitro studies on responses to pentoxifylline and aminophylline preparations from the proximal and distal colon of rats (261) 163 of rat mesenteric resistance vessels (261) 105 Mallet, P.E. and Beninger, R_J. Hara, H., see Harada, Y. (261) 91 7-OH-DPAT produces place conditioning in rats (261) RS Harada, Y., Hara, H. and Sukamoto, T. Manome, Y., see Sakurada, T. (261) 85 Binding properties of KB-5492, a novel anti-ulcer agent, at o Marano, G. and Argiolas, L. receptors in porcine gastric fundic mucosa (261) 91 Postjunctional regulation by angiotensin II of a,-adrenoceptor- Hata, F., see Maehara, T. (261) 163 mediated pressor responses in the rat (261) 121 Hayakawa, H., see Koumi, S.-i. (261) 213 Martinez, C., Vila, J.M., Aldasoro, M., Medina, P., Chuan, P. and Henquin, J.-C., see Guiot, Y. (261) 157 Lluch, S. Hernando, F., Fuentes, J.A., Roques, B.P. and Ruiz-Gayo, M. The human deferential artery: endothelium-mediated contraction The CCK, receptor antagonist, L-365,260, elicits antidepres- in response to adrenergic stimulation (261) 73 sant-type effects in the forced-swim test in mice (261) 257 Matsunaga, K., see Matsuno, K. (261) 43 Hillefors-Berglund, M. and Von Euler, G. Matsuno, K., Senda, T., Matsunaga, K. and Mita, S. Pharmacology of dopamine D, receptors in the islands of Calleja Ameliorating effects of o receptor ligands on the impairment of of the rat using quantitative receptor autoradiography (261) 179 passive avoidance tasks in mice: involvement in the central acetyl- Holman, R.B., see Thomas, D.N. (261) 53 cholinergic system (261) 43 Humphrey, P.P.A., see Feniuk, W. (261) 333 McDonald, F., see Pons, F. (261) 237 Humphrey, P.P.A., see Kennedy, I. (261) 273 Medina, P., see Martinez, C. (261) 73 Hunnicutt, Jr., E.J., Davis, J.N. and Chisholm, J.C. Melis, M.R., see Stancampiano, R. (261) 149 A new glibenclamide-insensitive neuroselective hyperpolarizing Mita, S., see Matsuno, K. (261) 43 agent (261) RI Modin, A., Weitzberg, E. and Lundberg, J.M. Nitric oxide regulates peptide release from parasympathetic nerves and vascular reactivity to vasoactive intestinal polypeptide lizuka, Y., see Fujibayashi, K. (261) 133 in vivo (261) 185 Imperato, A., Dazzi, L., Serra, M., Gessa, G.L. and Biggio, G. Molina-Holgado, E., see El Mansari, M. (261) 171 Differential effects of abecarnil on basal release of acetylcholine Montrucchio, G., see Emanuelli, G. (261) 265 and dopamine in the rat brain (261) 205 Mota-Filipe, H., see De Castro, M. (261) 199 Murai, T., Koshikawa, N., Kanayama, T., Takada, K., Tomiyama, K. Kadowitz, P.J., see Cheng, D.Y. (261) 223 and Kobayashi, M. Kanayama, T., see Murai, T. (261) 65 Opposite effects of midazolam and £-carboline-3-carboxylate Karunanithi, S., Lavidis, N.A. and Bennett, M.R. ethyl ester on the release of dopamine from rat nucleus accum- Effect of yohimbine on the contractile response of the mouse vas bens measured by in vivo microdialysis (261) 65 deferens to short, low frequency trains of nerve impulses (261) 17 Katsumata, K., see Sakurada, T. (261) 85 Nadel, J.A., see Ricciardolo, F.L.M. (261) 127 Kennedy, I. and Humphrey, P.P.A. Nalepa, I., see Papp, M. (261) 141 Evidence for the presence of two types of P, purinoceptor in the Nicolas, P., see Yin, Y. (261) 97 guinea-pig ileal longitudinal smooth muscle preparation (261) 273 Nijkamp, F.P., see De Kimpe, S.J. (261) 111 Kirk, S.A., see Pons, F. (261) 237 Nishimura, M., see Saeki, T. (261) 249 Kisara, K., see Sakurada, T. (261) 85 Nossaman, B.D., see Cheng, D.Y. (261) 223 Klint, T., see Albinsson, A. (261) 285 Nutt, D., see Thomas, D.N. (261) 53 Kobayashi, M., see Murai, T. (261) 65 Kobayashi, Y., Cavallotti, D., Ricci, A. and Amenta, F. Ohba, M., see Sakurada, T. (261) 85 Localisation of dopamine D,-like receptors in pulmonary artery of the human and rabbit but not of the rat (261) 229 Papp, M., Nalepa, I. and Vetulani, J. Koshikawa, N., see Murai, T. (261) 65 Reversal by imipramine of B-adrenoceptor up-regulation induced Koumi, S.-i., Sato, R. and Hayakawa, H. in a chronic mild stress model of depression (261) 141 Modulation of the delayed rectifier K*~ current by apamin in Perret, G.-Y., see Yin, Y. (261) 97 guinea-pig heart (261) 213 Pieretti, S., see Capasso, A. (261) 209 Author index / European Journal ofP harmacology 261 (1994) 339-341 Pons, F., Williams, T.J., Kirk, S.A.. McDonald, F. and Rossi, A.G. Skolnick, P., see Long, J.B. (261) 295 Pro-inflammatory and anti-inflammatory effects of the stable Smit, J., see Coppes, R.P. (261) 311 prostaglandin D, analogue, ZK 118.182 (261) 237 Sorrentino, L., see Capasso, A. (261) 209 Pugsley, M.K., Saint, D.A. and Walker, M.J.A. Sotnikova, T.D., see Gainetdinov, R.R. (261) 327 An electrophysiological basis for the antiarrhythmic actions of the Stancampiano, R., Melis, M.R. and Argiolas, A. «-opioid receptor agonist U-50,488H (261) 303 Penile erection and yawning induced by 5-HT,,. receptor agonists in male rats: relationship with dopaminergic and oxytocinergic Radja, F., see El Mansari, M. (261) 171 transmission (261) 149 Rahier, J., see Guiot, Y. (261) 157 Sukamoto, T., see Harada, Y. (261) 91 Rayevsky, K.S., see Gainetdinov, R.R. (261) 327 Suthamnatpong, N., see Machara, T. (261) 163 Reader, T.A., see El Mansari, M. (261) 171 Svartengren, J., see Albinsson, A. (261) 285 Reid, J.J., see Lieu, A.T. (261) 33 Ricci, A., see Kobayashi, Y. (261) 229 Takada, K., see Murai, T. (261) 65 Ricciardolo, F.L.M., Nadel, J.A., Bertrand, C., Yamawaki, 1., Chan, Takeuchi, T., see Maehara, T. (261) 163 B. and Geppetti, P. Tan-No, K., see Sakurada, T. (261) 85 Tachykinins and kinins in antigen-evoked plasma extravasation in Thomas, D.N., Nutt, D. and Holman, R.B. guinea-pig nasal mucosa (261) 127 Regionally specific changes in extracellular noradrenaline follow- Rodgers, RJ. and Cole, J.C. ing chronic idazoxan as revealed by in vivo microdialysis (261) 53 Anxiolytic-like effect of (SWAY 100135, a 5-HT,, receptor Tielemans, W., see De Kimpe, S.J. (261) 111 antagonist, in the murine elevated plus-maze test (261) 321 Tomiyama, K., see Murai, T. (261) 65 Roffel, A.F., see Coppes, R.P. (261) 311 Trabucchi, M., see Barbaccia, M.L. (261) 317 Roques, B.P., see Hernando, F. (261) 257 Roscetti, G., see Barbaccia, M.L. (261) 317 Uchida, T., see Saeki, T. (261) 249 Rossi, A.G., see Pons, F. (261) 237 Rouquier, L., Claustre, Y. and Benavides, J. Van Heuven-Nolsen, D., see De Kimpe, $_J. (261) 111 a,-Adrenoceptor antagonists differentially control serotonin re- Vanhoutte, P.M., see De Castro, M. (261) 199 lease in the hippocampus and striatum: a microdialysis study Vassy, R., see Yin, Y. (261)9 7 (261) 59 Vetulani, J., see Papp, M. (261) 141 Ruiz-Gayo, M., see Hernando, F. (261) 257 Vila, J.M., see Martinez, C. (261) 73 Von Euler, G., see Hillefors-Berglund, M. (261) 179 Saeki, T., Uchida, T., Nishimura, M., Fujinami, T. and Watanabe, Y. Block of Na* channel by moricizine hydrochloride in isolated Wahlestedt, C., see Adner, M. (261) 281 feline ventricular myocytes (261) 249 Walker, M.J.A., see Pugsley, M.K. (261) 303 Saint, D.A., see Pugsley, M.K. (261) 303 Watanabe, M., see Fujibayashi, K. (261) 133 Sakamoto, K., see Fujibayashi, K. (261) 133 Watanabe, Y., see Saeki, T. (261) 249 Sakurada, S., see Sakurada, T. (261) 85 Weitzberg, E., see Modin, A. (261) 185 Sakurada, T., Manome, Y., Katsumata, K., Tan-No, K., Sakurada, S., Williams, T.J., see Pons, F. (261) 237 Ohba, M. and Kisara, K. Comparison of antagonistic effects of sendide and CP-96,345 on a Yamawaki, |., see Ricciardolo, F.L.M. (261) 127 spinally mediated behavioural response in mice (261) 85 Yee, F., see Adner, M. (261) 281 Salford, L.G., see Adner, M. (261) 281 Yin, Y., Vassy, R., Nicolas, P., Perret, G.-Y. and Laurent, S. Sargent, C.A., Dzwonczyk, S. and Grover, G_J. Antagonism between T, and amiodarone on the contractility and The effect of a,-adrenoceptor antagonists in isolated globally the density of B-adrenoceptors of chicken cardiac myocytes (261) ischemic rat hearts (261) 25 97 Sato, R., see Koumi, S.-i. (261) 213 Young, G.A., see Haberny, K.A. (261) 1 Scott-Burden, T., see De Castro, M. (261) 199 Young, G.A., see Haberny, K.A. (261) 11 Senda, T., see Matsuno, K. (261) 43 Serra, M., see Imperato, A. (261) 205 Zaagsma, J., see Coppes, R.P. (261) 311 ELSEVIER European Journal of Pharmacology 261 (1994) 343-351 Key word index Abecarnil B-Adrenoceptor GABA, receptor; Dopamine; Acetylcholine, release (Imperato, A. Chronic mild stress; Depression model, rat; Imipramine, chronic; (261) 205) cAMP; Sucrose intake (Papp, M. (261) 141) Acetylcholine w-Agatoxin-IVA Nitric oxide (NO); VIP (vasoactive intestinal polypeptide); Neu- w-Conotoxin-GVIA; Ca** channel (voltage sensitive); Autonomic ropeptide Y; Nitroprusside; Milrinone; cAMP; cGMP (Modin, A. nerve; Neurotransmission; Smooth muscle (Lundy, P.M. (261) 79) (261) 185) Airway Hippocampus; Medial septal area; Nicotinic acetylcholine receptor; Kinin; Tachykinin; Antigen; Plasma extravasation; Neutral endopep- Spatial memory (Decker, M.W. (261) 217) tidase (Ricciardolo, F.L.M. (261) 127) Acetylcholine, release Aminophylline Abecarnil; GABA, receptor; Dopamine (Imperato, A. (261) 205) Pentoxifylline; Mesenteric resistance vessel; Endothelium; Nitric ox- ide (NO); Smooth muscle, vascular; Methylxanthine derivative (Han- Acetylcholinergic neuronal system sen, P.R. (261) 105) o Receptor ligand; SKF-10,047; DTG (1,3-di-(2-tolyl)guanidine); Benzomorphan-type o receptor; p-Chloroamphetamine; Amnesia; Amiodarone Passive avoidance task; (+ )-3-PPP (( + )-3-(3-hydroxyphenyl)-N-(1- Triiodothyronine; B-adrenoceptor; Cardiomyocyte; (Chicken) (Yin, propyl )piperizine); (Mouse) (Matsuno, K. (261) 43) Y. (261) 97) ACPC (1 ycloprop arboxylic acid) Amnesia NMDA (N-methyl-p-aspartate); Neuronal injury; dynorphin A; o@ Receptor ligand; SKF-10,047; DTG (1,3-di-(2-tolyl)guanidine),; Glycine (Long, J.B. (261) 295) Benzomorphan-type o receptor; Acetylcholinergic neuronal system; p-Chloroamphetamine; Passive avoidance task; (+ )-3-PPP ((+ )-3- Action potential (3-hydroxyphenyl)-N-(1-propyl)piperizine); (Mouse) (Matsuno, K. Apamin; Patch-clamp technique; Delayed rectifier K* current; Ven- (261) 43) tricular myocyte (Koumi, S.-i. (261) 213) cAMP Adenosine receptor Chronic mild stress; Depression model, rat; Imipramine, chronic; Nucleus accumbens; Dopamine release; Midazolam; B-CCE (,- B-Adrenoceptor; Sucrose intake (Papp, M. (261) 141) carboline-3-carboxylate ethyl ester); GABA , /benzodiazepine recep- tor (Murai, T. (261) 65) Nitric oxide (NO); VIP (vasoactive intestinal polypeptide); Neu- ropeptide Y; Nitroprusside; Milrinone; cGMP; Acetylcholine (Modin, Adherence A. (261) 185) Inflammation; Prostaglandin D,; Neutrophil; Edema formation; O; production (Pons, F. (261) 237) Angiotensin-(1-7) Angiotensin II; Angiotensin-3—8) /angiotensin IV; Vasoconstriction; Adrenergic stimulation Pulmonary circulation; Angiotensin AT, receptor antagonist; An- Deferential artery, human; Endothelium (Martinez, C. (261) 73) giotensin AT, receptor antagonist (Cheng, D.Y. (261) 223) a ,-Adrenoceptor Angiotensin-(3-8)/ angiotensin IV 5-HT (5-hydroxytryptamine, serotonin); Microdialysis (Rouquier, L. Angiotensin II; Angiotensin{1-—7); Vasoconstriction; Pulmonary cir- (261) 59) culation; Angiotensin AT, receptor antagonist; Angiotensin AT, receptor antagonist (Cheng, D.Y. (261) 223) Angiotensin I]; Sympathetic nervous system; Valsartan; PD 123319 (Marano, G. (261) 121) Angiotensin AT, receptor Angiotensin Il; Angiotensin-(3-8)/angiotensin IV; Angiotensin41- a ,-adrenoceptor antagonist 7); Vasoconstriction; Pulmonary circulation; Angiotensin AT, recep- 5-HT (S-hydroxytryptamine, serotonin); Myocardial ischemia (Sar- tor antagonist (Cheng, D.Y. (261) 223) gent, C.A. (261) 25) Angiotensin AT, receptor antagonist a ,-Adrenoceptor, presynaptic Angiotensin I]; Angiotensin-3-—8)/angiotensin IV; Angiotensin-(1- Frontal cortex; Hippocampus; Idazoxan, chronic; Microdialysis 7); Vasoconstriction; Pulmonary circulation; Angiotensin AT, recep- (Thomas, D.N. (261) 53) tor antagonist (Cheng, D.Y. (261) 223) 344 Key word index / European Journal of Pharmacology 261 (1994) 343-351 Angiotensin II B-adrenoceptor Sympathetic nervous system; a ,-Adrenoceptor; Valsartan; PD 123319 Amiodarone; Triiodothyronine; Cardiomyocyte; (Chicken) (Yin, Y. (Marano, G. (261) 121) (261) 97) Angiotensin-(3—8)/angiotensin IV; Angiotensin-(1—7); Vasoconstric- BC-264 tion; Pulmonary circulation; Angiotensin AT, receptor antagonist; CCK receptor antagonist; CCK-8; Dopamine; Nomifensine; Depres- Angiotensin AT, receptor antagonist (Cheng, D.Y. (261) 223) sion; L-365,260 (Hernando, F. (261) 257) Antigen Benzomorphan-type o receptor Kinin; Tachykinin; Plasma extravasation; Airway; Neutral endopepti- o Receptor ligand; SKF-10,047; DTG (1,3-di-(2-tolyl)guanidine), dase (Ricciardolo, F.L.M. (261) 127) Acetylcholinergic neuronal system; p-Chloroamphetamine; Amnesia; Passive avoidance task; (+)-3-PPP ((+)-3-(3-hydroxyphenyl)-N-(1- Antinociceptive effect propyl)piperizine); (Mouse) (Matsuno, K. (261) 43) «x-Opioid receptor agonist; R-84760; U-50488; CI-977; Morphine (Fujibayashi, K. (261) 133) BIM 23027 Somatostatin; Pertussis toxin; G-protein; Seglitide; SRIF receptor; Antisense oligod leotid Vas deferens, mouse (Feniuk, W. (261) 333) Endothelin ET, receptor; Temporal artery, human (Adner, M. (261) 281) Bisoxonol Neuroselectivity; K* channel (Hunnicutt, Jr., E.J. (261) R1) Anti-ulcer agent DTG (1,3-di(2-tolyl)guanidine); KB-5492; Mucosa; 0 Receptor; SKF Bradykinin 10,047 (N-allyl-normetazocine); (Pig) (Harada, Y. (261) 91) Interferon-y; Arterial reactivity; Nitric oxide (NO) (De Kimpe, S.J. (261) 111) Anxiety Elevated plus-maze; 5-HT,, receptor; 5-HT,, receptor antagonist; Brain, rat (S)-WAY 100135; (Mouse) (Rodgers, R.J. (261) 321) Neurosteroid; Stress; Handling; CO, (Barbaccia, M.L. (261) 317) Apamin Ca?* channel (voltage sensitive) Patch-clamp technique; Action potential; Delayed rectifier K* cur- w-Agatoxin-IVA; w-Conotoxin-GVIA; Autonomic nerve; Neuro- rent; Ventricular myocyte (Koumi, S.-i. (261) 213) transmission; Smooth muscle (Lundy, P.M. (261) 79) Apomorphine Cage leaving 5-HT receptor agonist; 5-HT receptor antagonist; Oxytocin; Penile FG5893; 5-HT,, receptor agonist /S-HT,, receptor antagonist; 5-HT erection; Yawning; (Rat) (Stancampiano, R. (261) 149) receptor; Hypothermia; Head twitch behavior; Passive avoidance; Forced swim test; Ultrasound vocalization; Corticosterone; (Rat) Arterial reactivity (Albinsson, A. (261) 285) Interferon-y; Bradykinin; Nitric oxide (NO) (De Kimpe, S.J. (261) 111) Cardiac electrophysiology lonic current; Cardiac myocyte, isolated; x-Opioid receptor agonist; ATP U-50,488H (Pugsley, M.K. (261) 303) Vas deferens, mouse; Cotransmission; Facilitation; Yohimbine; a,- Autoinhibition (Karunanithi, S. (261) 17) Cardiac myocyte, isolated Cardiac electrophysiology; lonic current; «-Opioid receptor agonist; Atrium, rat U-50,488H (Pugsley, M.K. (261) 303) Diabetes; Endothelin-1; Noradrenaline; Streptozotocin; Sympathetic nerve stimulation (Lieu, A.T. (261) 33) Cardiomyocyte Amiodarone; Triiodothyronine; B-adrenoceptor; (Chicken) (Yin, Y. a ,-Autoinhibition (261) 97) Vas deferens, mouse; Cotransmission; ATP; Facilitation; Yohimbine (Karunanithi, S. (261) 17) Catecholamine histofluorescence Pulmonary artery; Dopamine D, receptor; Radioligand binding; Autonomic nerve Autoradiography; Prejunctional receptor (Kobayashi, Y. (261) 229) w-Agatoxin-IVA; w-Conotoxin-GVIA; Ca** channel (voltage sensi- tive); Neurotransmission; Smooth muscle (Lundy, P.M. (261) 79) B-CCE ( B-carboline-3-carboxylate ethyl ester) Nucleus accumbens; Dopamine release; Midazolam; GAB, A/be n- Autoradiography zodiazepine receptor; Adenosine receptor (Murai, T. (261) 65) 5-HT,, receptor; 5-HT,, receptor; 5-HT,. receptor; 6-Hydroxy- dopamine; mCPP (1-3-(m-chlorophenyl)piperazine); DOI (1-(2,5-di- CCK-8 methoxy-4-iodopheny!)-2-aminopropane); lontophoresis (El Mansari, CCK receptor antagonist; BC-264; Dopamine; Nomifensine; Depres- M. (261) 171) sion; L-365,260 (Hernando, F. (261) 257) Pulmonary artery; Dopamine D, receptor; Radioligand binding; CCK receptor antagonist Catecholamine histofluorescence; Prejunctional receptor (Kobayashi, CCK-8; BC-264; Dopamine; Nomifensine; Depression; L-365,260 Y. (261) 229) (Hernando, F. (261) 257) Key word index / European Journal of Pharmacology 261 (1994) 343-351 Cell culture Depression model, rat Interleukin-18; Lipopolysaccharide; Nitric oxide (NO); p1i-pro- Chronic mild stress; Imipramine, chronic; cAMP; B-Adrenoceptor; pranolol; Smooth muscle, vascular; Spontaneously hypertensive rat Sucrose intake (Papp, M. (261) 141) (SHR); Wistar Kyoto rat (WKY); (Rat) (De Castro, M. (261) 199) Diabetes B-Cell replication Atrium, rat; Endothelin-1; Noradrenaline; Streptozotocin; Sympa- Glibenclamide; Sulphonylurea; Diabetes; Pancreatic islet (Guiot, Y. thetic nerve stimulation (Lieu, A.T. (261) 33) (261) 157) Glibenclamide; Sulphonylurea; 8-Cell replication; Pancreatic islet p-Chloroamphetamine (Guiot, Y. (261) 157) o Receptor ligand; SKF-10,047; DTG (1,3-di-2-tolyl)guanidine),; Benzomorphan-type o receptor; Acetylcholinergic neuronal system; DL-propranolol Amnesia; Passive avoidance task; (+)-3-PPP ((+ )-3-3-hydroxy- Interleukin-18 ; Lipopolysaccharide; Nitric oxide (NO), Smooth mus- phenyl)-N-(1-propyl)piperizine); (Mouse) (Matsuno, K. (261) 43) cle, vascular; Cell culture; Spontaneously hypertensive rat (SHR); Chronic mild stress Wistar Kyoto rat (WKY); (Rat) (De Castro, M. (261) 199) Depression model, rat; Imipramine, chronic; cAMP; B-Adrenocep- tor; Sucrose intake (Papp, M. (261) 141) DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane) 5-HT,, receptor; 5-HT,, receptor; 5-HT,,. receptor; 6-Hydroxy- Cl-977 dopamine; mCPP (1-3-(m-chlorophenyl)piperazine), lontophoresis; «-Opioid receptor agonist; R-84760; U-50488; Morphine; Antinoci- Autoradiography (El Mansari, M. (261) 171) ceptive effect (Fujibayashi, K. (261) 133) Dopamine co, Abecarnil; GABA, receptor; Acetylcholine, release (Imperato, A. Neurosteroid; Stress; Handling; Brain, rat (Barbaccia, M.L. (261) (261) 205) 317) CCK receptor antagonist; CCK-8; BC-264; Nomifensine; Depression; Colon L-365,260 (Hernando, F. (261) 257) Skinned muscle; cGMP; NAMC (non-adrenergic, non-cholinergic) inhibition; (Rat) (Maehara, T. (261) 163) Dopamine D, receptor Pulmonary artery; Radioligand binding; Autoradiography; Cate- w-Conotoxin-GVIA cholamine histofluorescence; Prejunctional receptor (Kobayashi, Y. w-Agatoxin-IVA; Ca** channel (voltage sensitive); Autonomic nerve; (261) 229) Neurotransmission; Smooth muscle (Lundy, P.M. (261) 79) Dopamine release; Dopamine metabolism; Dopamine D, receptor; Corticosterone Neuroleptic; Microdialysis (Gainetdinov, R.R. (261) 327) FG5893; 5-HT,, receptor agonist /5-HT,, receptor antagonist; 5-HT receptor; Hypothermia; Head twitch behavior; Passive avoidance; Forced swim test; Cage leaving; Ultrasound vocalization; (Rat) (Al- Dopamine D, receptor binsson, A. (261) 285) Dopamine release; Dopamine metabolism; Dopamine D, receptor; Neuroleptic; Microdialysis (Gainetdinov, R.R. (261) 327) Cotransmission Vas deferens, mouse; ATP; Facilitation; Yohimbine; a,-Autoinhibi- 7-OH-DPAT ((+)-2-dipropylamino-7-hydroxy-1,2,3,4-tetrahydro- tion (Karunanithi, S. (261) 17) naphthalene hydrobromide); Place conditioning (Mallet, P.E. (261) RS) mCPP (1-3-(m-chloropheny!) piperazine) 5-HT,, receptor; 5-HT,, receptor; 5-HT,. receptor; 6-Hydroxy- Dopamine metabolism dopamine; DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane),; Dopamine release; Dopamine D, receptor; Dopamine D, receptor; lontophoresis; Autoradiography (El Mansari, M. (261) 171) Neuroleptic; Microdialysis (Gainetdinov, R.R. (261) 327) DBA /2J mouse Dopamine release B-Endorphin fragment; Neocortical spike-and-wave spindling; Elec- Nucleus accumbens; Midazolam; B-CCE (f-carboline-3-carboxylate trocorticogram (Capasso, A. (261) 209) ethyl ester); GABA, /benzodiazepine receptor; Adenosine receptor (Murai, T. (261) 65) Deferential artery, human Endothelium; Adrenergic stimulation (Martinez, C. (261) 73) Dopamine metabolism; Dopamine D, receptor; Dopamine D, re- Delayed rectifier K * current ceptor; Neuroleptic; Microdialysis (Gainetdinov, R.R. (261) 327) Apamin; Patch-clamp technique; Action potential; Ventricular my- ocyte (Koumi, S.-i. (261) 213) DTG (1,3-di-(2-tolyl) guanidine) o Receptor ligand; SKF-10,047; Benzomorphan-type o receptor; Dependence Acetylcholinergic neuronal system; p-Chloroamphetamine; Amnesia; Morphine; MK-801; EEG (electroencephalography); EEG power Passive avoidance task; (+)-3-PPP ((+ )-343-hydroxyphenyl)-N-(1- spectra; (Interaction) (Haberny, K.A. (261) 11) propyl)piperizine); (Mouse) (Matsuno, K. (261) 43) Depression DTG (1,3-di(2-tolyl)guanidine) CCK receptor antagonist; CCK-8; BC-264; Dopamine; Nomifensine; Anti-ulcer agent; KB-5492; Mucosa; a Receptor; SKF 10,047 (N-al- L-365,260 (Hernando, F. (261) 257) lyl-normetazocine); (Pig) (Harada, Y. (261) 91) 346 Key word index / European Journal of Pharmacology 261 (1994) 343-351 Dynorphin A Frontal cortex ACPC (1-aminocyclopropanecarboxylic acid); NMDA (N-methyl-p- Hippocampus; Idazoxan, chronic; Microdialysis; aj-Adrenoceptor, aspartate); Neuronal injury; Glycine (Long, J.B. (261) 295) presynaptic (Thomas, D.N. (261) 53) Edema formation GABA , / benzodiazepine receptor Inflammation; Prostaglandin D,; Neutrophil; Adherence; O, pro- Nucleus accumbens; Dopamine release; Midazolam; B-CCE (- duction (Pons, F. (261) 237) carboline-3-carboxylate ethyl ester); Adenosine receptor (Murai, T. (261) 65) EEG (electroencephalography) Morphine; MK-801; EEG power spectra; Tolerance; (Interaction) GABA, receptor (Haberny, K.A. (261) 1) Abecarnil; Dopamine; Acetylcholine, release (Imperato, A. (261) 205) Morphine; MK-801; EEG power spectra; Dependence; (Interaction) (Haberny, K.A. (261) 11) Glibenclamide EEG power spectra Sulphonylurea; B-Cell replication; Diabetes; Pancreatic islet (Guiot, Morphine; MK-801; EEG (electroencephalography); Tolerance; (In- Y. (261) 157) teraction) (Haberny, K.A. (261) 1) Glycine Morphine; MK-801; EEG (electroencephalography); Dependence; ACPC (1-aminocyclopropanecarboxylic acid); NMDA (N-methyl-p- (Interaction) (Haberny, K.A. (261) 11) aspartate); Neuronal injury; dynorphin A (Long, J.B. (261) 295) Electrocorticogram cGMP B-Endorphin fragment; Neocortical spike-and-wave spindling; Skinned muscle; Colon; NAMC (non-adrenergic, non-cholinergic) DBA/2J mouse (Capasso, A. (261) 209) inhibition; (Rat) (Maehara, T. (261) 163) Elevated plus-maze Anxiety; 5-HT,, receptor; 5-HT,, receptor antagonist; (S)-WAY Nitric oxide (NO); VIP (vasoactive intestinal polypeptide); Neu- 100135; (Mouse) (Rodgers, R.J. (261) 321) ropeptide Y; Nitroprusside; Milrinone; cAMP; Acetylcholine (Modin, A. (261) 185) B-Endorphin fragment Neocortical spike-and-wave spindling; Electrocorticogram; DBA/2J G-protein mouse (Capasso, A. (261) 209) Somatostatin; Pertussis toxin; Seglitide; BIM 23027; SRIF receptor; Vas deferens, mouse (Feniuk, W. (261) 333) Endothelin-1 Atrium, rat; Diabetes; Noradrenaline; Streptozotocin; Sympathetic H nerve stimulation (Lieu, A.T. (261) 33) 7-OH-DPAT (7-hydroxy-2-( NV,N -di-n-propylamino)tetralin); Remox- ipride; R(—)-Propylnorapomorphine; Raclopride (Hillefors- Endothelin ET, receptor Berglund, M. (261) 179) Antisense oligodeoxynucleotide; Temporal artery, human (Adner, M. (261) 281) Handling Neurosteroid; Stress; CO,; Brain, rat (Barbaccia, M.L. (261) 317) Endothelium Deferential artery, human; Adrenergic stimulation (Martinez, C. (261) 73) Head twitch behavior FGS5893; 5-HT,, receptor agonist /5-HT,, receptor antagonist; 5-HT Pentoxifylline; Mesenteric resistance vessel; Aminophylline; Nitric receptor; Hypothermia; Passive avoidance; Forced swim test; Cage oxide (NO); Smooth muscle, vascular; Methylxanthine derivative leaving; Ultrasound vocalization; Corticosterone; (Rat) (Albinsson, (Hansen, P.R. (261) 105) A. (261) 285) Endotoxin Hippocampus Pancreatitis, acute; PAF (platelet activating factor) (Emanuelli, G. Frontal cortex; Idazoxan, chronic; Microdialysis; a ,-Adrenoceptor, (261) 265) presynaptic (Thomas, D.N. (261) 53) Facilitation Acetylcholine; Medial septal area; Nicotinic acetylcholine receptor; Vas deferens, mouse; Cotransmission; ATP; Yohimbine; a,-Autoin- Spatial memory (Decker, M.W. (261) 217) hibition (Karunanithi, S. (261) 17) 5-HT (5-hydroxytryptamine, serotonin) FG5893 a,-adrenoceptor antagonist; Myocardial ischemia (Sargent, C.A. (261) 5-HT,, receptor agonist /5-HT,, receptor antagonist; 5-HT recep- 25) tor; Hypothermia; Head twitch behavicr; Passive avoidance; Forced swim test; Cage leaving; Ultrasound vocalization; Corticosterone; (Rat) (Albinsson, A. (261) 285) a,-Adrenoceptor; Microdialysis (Rouquier, L. (261) 59) Forced swim test 5-HT receptor FG5893; 5-HT,, receptor agonist /5-HT,, receptor antagonist; 5-HT FG5893; 5-HT,, receptor agonist /5-HT,, receptor antagonist; Hy- receptor; Hypothermia; Head twitch behavior; Passive avoidance; pothermia; Head twitch behavior; Passive avoidance; Forced swim Cage leaving; Ultrasound vocalization; Corticosterone; (Rat) (Albins- test; Cage leaving; Ultrasound vocalization; Corticosterone; (Rat) son, A. (261) 285) (Albinsson, A. (261) 285) Key word index / European Journal of Pharmacology 261 (1994) 343-351 5-HT,, receptor Interferon-y Anxiety; Elevated plus-maze; 5-HT,, receptor antagonist; (S)-WAY Arterial reactivity; Bradykinin; Nitric oxide (NO) (De Kimpe, S.J. 100135; (Mouse) (Rodgers, R.J. (261) 321) (261) 111) 5-HT,, receptor Interleukin-18 5-HT,, receptor; 5-HT,,. receptor; 6-Hydroxydopamine; mCPP (1-3- Lipopolysaccharide; Nitric oxide (NO); pt-propranolol; Smooth mus- (m-chlorophenyl)piperazine); DOI (1-(2,5-dimethoxy-4-iodophenyl)- cle, vascular; Cell culture; Spontaneously hypertensive rat (SHR); 2-aminopropane); Iontophoresis; Autoradiography (El Mansari, M. Wistar Kyoto rat (WKY); (Rat) (De Castro, M. (261) 199) (261) 171) Intrathecal injection 5-HT,, receptor Tachykinin receptor antagonist; Spinal cord; (Mouse) (Sakurada, T. 5-HT), receptor; 5-HT,.. receptor; 6-Hydroxydopamine; mCPP (1-3- (261) 85) (m-chloropheny])piperazine); DOI (1-(2,5-dimethoxy-4-iodophenyl)- 2-aminopropane); lontophoresis; Autoradiography (El Mansari, M. lonic current (261) 171) Cardiac electrophysiology; Cardiac myocyte, isolated; x-Opioid re- ceptor agonist; U-50,488H (Pugsley, M.K. (261) 303) 5-HT,< receptor 5-HT\, receptor; 5-HT,, receptor; 6-Hydroxydopamine; mCPP (1-3- lontophoresis (m-chlorophenyl)piperazine), DOI (1-(2,5-dimethoxy-4-iodopheny])- 5-HT\, receptor; 5-HT,, receptor; 5-HT,. receptor; 6-Hydroxy- 2-aminopropane); lontophoresis; Autoradiography (El Mansari, M. dopamine; mCPP (1-3-(m-chlorophenyl)piperazine); DOI (1-42,5-di- (261) 171) methoxy-4-iodophenyl)-2-aminopropane), Autoradiography (El Man- sari, M. (261) 171) 5-HT receptor agonist 5-HT receptor antagonist; Apomorphine; Oxytocin; Penile erection; KB-5492 Yawning; (Rat) (Stancampiano, R. (261) 149) Anti-ulcer agent; DTG (1,3-di(2-tolyl)guanidine); Mucosa; a Recep- tor; SKF 10,047 (N-allyl-normetazocine), (Pig) (Harada, Y. (261) 91) 5-HT,, receptor agonist /5-HT,, receptor antagonist FG5893; 5-HT receptor; Hypothermia; Head twitch behavior; Pas- K* channel sive avoidance; Forced swim test; Cage leaving; Ultrasound vocaliza- Bisoxonol; Neuroselectivity (Hunnicutt, Jr., EJ. (261) R1) tion; Corticosterone; (Rat) (Albinsson, A. (261) 285) Kinin 5-HT receptor antagonist Tachykinin; Antigen; Plasma extravasation; Airway; Neutral en- 5-HT receptor agonist; Apomorphine; Oxytocin; Penile erection; dopeptidase (Ricciardolo, F.L.M. (261) 127) Yawning; (Rat) (Stancampiano, R. (261) 149) L-365,260 5-HT,, receptor antagonist CCK receptor antagonist; CCK-8; BC-264; Dopamine; Nomifensine; Anxiety; Elevated plus-maze; 5-HT,, receptor; (S)}WAY 100135; Depression (Hernando, F. (261) 257) (Mouse) (Rodgers, R.J. (261) 321) [Leu*',Pro™ ]Neuropeptide Y 6-Hydroxydopamine Prejunctional receptor; Noradrenaline overflow, evoked; Neuropep- 5-HT,, receptor; 5-HT,, receptor; 5-HT,. receptor; mCPP (1-3- tide Y; Neuropeptide Y-(18-36), Portal vein; (Freely moving rat) (m-chlorophenyl)piperazine), DOI (1-(2,5-dimethoxy-4-iodophenyl)- (Coppes, R.P. (261) 311) 2-aminopropane), lontophoresis; Autoradiography (El Mansari, M. (261) 171) Lipopolysaccharide Interleukin-18; Nitric oxide (NO); pi-propranolol; Smooth muscle, vascular; Cell culture; Spontaneously hypertensive rat (SHR); Wistar FG5893; 5-HT,, receptor agonist /5-HT,, receptor antagonist; 5-HT Kyoto rat (WKY); (Rat) (De Castro, M. (261) 199) receptor; Head twitch behavior; Passive avoidance; Forced swim test; Cage leaving; Ultrasound vocalization; Corticosterone; (Rat) (Albin- Medial septal area sson, A. (261) 285) Acetylcholine; Hippocampus; Nicotinic acetylcholine receptor; Spa- tial memory (Decker, M.W. (261) 217) Idazoxan, chronic Frontal cortex; Hippocampus; Microdialysis; a»-Adrenoceptor, Mesenteric resistance vessel presynaptic (Thomas, D.N. (261) 53) Pentoxifylline; Aminophylline; Endothelium; Nitric oxide (NO); Smooth muscle, vascular; Methylxanthine derivative (Hansen, P.R. Ileal longitudinal muscle, guinea pig (261) 105) Px purinoceptor; P,y purinoceptor; a,8-Methylene ATP; 2-Methyl- thio ATP; B,y-Methylene ATP (Kennedy, I. (261) 273) a,B-Methylene ATP Ileal longitudinal muscle, guinea pig; P,, purinoceptor; P»y Imipramine, chronic purinoceptor; 2-Methylithio ATP; 8,y-Methylene ATP (Kennedy, I. Chronic mild stress; Depression model, rat; cAMP; B-Adrenoceptor; (261) 273) Sucrose intake (Papp, M. (261) 141) B,y-Methylene ATP Inflammation Ileal longitudinal muscle, guinea pig; P,x purinoceptor; P» Prostaglandin D,; Neutrophil; Edema formation; Adherence; O; purinoceptor; a,B-Methylene ATP; 2-Methylthio ATP (Kennedy, I. production (Pons, F. (261) 237) (261) 273) 348 Key word index / European Journal of Pharmacology 261 (1994) 343-351 2-Methylthio ATP Neocortical spike-and-wave spindling Ileal longitudinal muscle, guinea pig; Pj, purinoceptor; Py B-Endorphin fragment; Electrocorticogram; DBA/2J mouse (Capas- purinoceptor; a,8-Methylene ATP; B,y-Methylene ATP (Kennedy, so, A. (261) 209) I. (261) 273) Neuroleptic ine derivative Dopamine release; Dopamine metabolism; Dopamine D, receptor; Pentoxifylline; Mesenteric resistance vessel; Aminophylline; En- Dopamine D, receptor; Microdialysis (Gainetdinov, R.R. (261) 327) dothelium; Nitric oxide (NO); Smooth muscle, vascular (Hansen, P.R. (261) 105) Neuronal injury ACPC (1-aminocyclopropanecarboxylic acid); NMDA (N-methyl-p- Microdialysis aspartate); dynorphin A; Glycine (Long, J.B. (261) 295) Frontal cortex; Hippocampus; Idazoxan, chronic; a,-Adrenoceptor, presynaptic (Thomas, D.N. (261) 53) Neuropeptide Y Nitric oxide (NO); VIP (vasoactive intestinal polypeptide), Nitroprus- a,-Adrenoceptor; 5-HT (5-hydroxytryptamine, serotonin) (Rouquier, side; Milrinone; cAMP; cGMP; Acetylcholine (Modin, A. (261) 185) L. (261) 59) Prejunctional receptor; Noradrenaline overflow, evoked; [Leu*',- Pro*™ JNeuropeptide Y; Neuropeptide Y-(18-36); Portal vein; (Freely Dopamine release; Dopamine metabolism; Dopamine D, receptor; Dopamine D, receptor; Neuroleptic (Gainetdinov, R.R. (261) 327) moving rat) (Coppes, R.P. (261) 311) Midazolam Neuropeptide Y-(18-36) Nucleus accumbens; Dopamine release; B-CCE (f-carboline-3- Prejunctional receptor; Noradrenaline overflow, evoked; Neuropep- tide Y; [Leu*',Pro™“ Neuropeptide Y; Portal vein; (Freely moving carboxylate ethyl ester); GABA, /benzodiazepine receptor; Adeno- sine receptor (Murai, T. (261) 65) rat) (Coppes, R.P. (261) 311) Neuroselectivity Milrinone Bisoxonol; K* channel (Hunnicutt, Jr., EJ. (261) R1) Nitric oxide (NO); VIP (vasoactive intestinal polypeptide); Neu- ropeptide Y; Nitroprusside; cAMP; cGMP; Acetylcholine (Modin, A. (261) 185) Neurosteroid Stress; Handling; CO,; Brain, rat (Barbaccia, M.L. (261) 317) MK-801 Goat Morphine; EEG (electroencephalography); EEG power spectra; Tol- w-Agatoxin-IVA; w-Conotoxin-GVIA; Ca?* channel (voltage sensi- erance; (Interaction) (Haberny, K.A. (261) 1) tive); Autonomic nerve; Smooth muscle (Lundy, P.M. (261) 79) Morphine; EEG (electroencephalography); EEG power spectra; De- Neutral endopeptidase pendence; (Interaction) (Haberny, K.A. (261) 11) Kinin; Tachykinin; Antigen; Plasma extravasation; Airway (Ric- ciardolo, F.L.M. (261) 127) Moricizine hydrochloride Na” current; Ventricular myocyte, single, feline; Voltage clamp, Neutrophil whole cell (Saeki, T. (261) 249) Inflammation; Prostaglandin D,; Edema formation; Adherence; O; production (Pons, F. (261) 237) Morphine MK-801; EEG (electroencephalography); EEG power spectra; Toler- Nicotinic acetylcholine receptor ance; (Interaction) (Haberny, K.A. (261) 1) Acetylcholine; Hippocampus; Medial septal area; Spatial memory (Decker, M.W. (261) 217) MK-801; EEG (electroencephalography); EEG power spectra; De- pendence; (Interaction) (Haberny, K.A. (261) 11) Nitric oxide (NO) Pentoxifylline; Mesenteric resistance vessel; Aminophylline; En- «-Opioid receptor agonist; R-84760; U-50488; CI-977; Antinocicep- dothelium; Smooth muscle, vascular; Methylxanthine derivative tive effect (Fujibayashi, K. (261) 133) (Hansen, P.R. (261) 105) Mucosa Interferon-y; Arterial reactivity; Bradykinin (De Kimpe, S.J. (261) Anti-ulcer agent; DTG (1,3-di(2-tolyl guanidine); KB-5492; o Recep- 111) tor; SKF 10,047 (N-allyl-normetazocine); (Pig) (Harada, Y. (261) 91) VIP (vasoactive intestinal polypeptide); Neuropeptide Y; Nitroprus- Myocardial ischemia side; Milrinone; cAMP; cGMP; Acetylcholine (Modin, A. (261) 185) a,-adrenoceptor antagonist; 5-HT (5-hydroxytryptamine, serotonin) (Sargent, C.A. (261) 25) Interleukin-18 ; Lipopolysaccharide; pi-propranolol; Smooth muscle, vascular; Cell culture; Spontaneously hypertensive rat (SHR); Wistar Na* current Kyoto rat (WKY); (Rat) (De Castro, M. (261) 199) Moricizine hydrochloride; Ventricular myocyte, single, feline; Volt- age clamp, whole cell (Saeki, T. (261) 249) Nitroprusside Nitric oxide (NO); VIP (vasoactive intestinal polypeptide); Neu- NAMC (non-adrenergic, non-cholinergic) inhibition ropeptide Y; Milrinone; cAMP; cGMP; Acetylcholine (Modin, A. Skinned muscle; cGMP; Colon; (Rat) (Maehara, T. (261) 163) (261) 185)

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.